Skip to main content

Closed

LUNG: Pulmonx Corporation Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+22.0% / yr

Operating margin-53.0%

ROIC-48.4%

Financially safe

Stretched

Debt / equity1.43×

Interest coverage-12.3×

Current ratio4.32×

Pulmonx Corporation

LUNGNASDAQ Global Select·USD·Closed

Pulmonx Corporation

LUNGNASDAQ·USD·Closed

$1.63

+1.24%

$1.63

+$0.02 (1.24%)

52W Range

28thpctl

Volume

3.28×avg

Mkt Cap

68.85MUSD

P/E

-1.4TTM

Div Yield

–ann

52W Range

28thpctl

Volume

3.28×avg

Market Cap

68.85MUSD

P/E Ratio

-1.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings